| Field | Row 1 |
|---|---|
| adsh | 0001213900-25-044193 |
| cik | 1176309 |
| name | ORAMED PHARMACEUTICALS INC. |
| sic | 2834 |
| countryba | US |
| stprba | NY |
| cityba | NEW YORK |
| zipba | 10036 |
| bas1 | 1185 AVENUE OF THE AMERICAS, 3RD FLOOR |
| bas2 | |
| baph | 646-844-1164 |
| countryma | US |
| stprma | NY |
| cityma | NEW YORK |
| zipma | 10036 |
| mas1 | 1185 AVENUE OF THE AMERICAS, 3RD FLOOR |
| mas2 | |
| countryinc | US |
| stprinc | DE |
| ein | 980376008 |
| former | INTEGRATED SECURITY TECHNOLOGIES, INC. |
| changed | 20040614 |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250515 |
| accepted | 2025-05-15 16:07:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | ea0241687-10q_oramed_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001213900-25-044193 | 20250331 | Advance Payments For Real Estate | 1221000.0000 | USD | 0 | 0001213900-25-044193 | |||
| 0001213900-25-044193 | 20241231 | Assets Current | 143221000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 18576000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 20096000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-044193 | 20250331 | Common Stock Shares Issued | 350000.0000 | shares | 0 | us-gaap/2025 | Related Party Transactions By Related Party= Scilex Common Stock; | ||
| 0001213900-25-044193 | 20241231 | Common Stock Shares Outstanding | 39919545.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20241231 | Common Stock Value | 480000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20241231 | Deposits Assets Current | 55281000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Depreciation | 56000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Employee Rights Upon Retirement Noncurrent | 33000.0000 | USD | 0 | 0001213900-25-044193 | |||
| 0001213900-25-044193 | 20250331 | Gain On Amounts Funded In Respect Of Employee Rights Upon Retirement | USD | 1 | 0001213900-25-044193 | ||||
| 0001213900-25-044193 | 20250331 | General And Administrative Expense | 2307000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Increase Decrease In Accounts Payable And Accrued Liabilities | -666000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Increase Decrease In Contract With Customer Liability | -2000000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Increase Decrease In Operating Lease Liability | 3000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -36000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20241231 | Investment Owned At Fair Value | 1976000.0000 | USD | 0 | us-gaap/2025 | Investment Type= Royalty Purchase Agreement; Vesting= Share Based Compensation Award Tranche Two; | ||
| 0001213900-25-044193 | 20250331 | Liabilities Current | 5492000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Liabilities Noncurrent | 2153000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Noncontrolling Interest Increase From Subsidiary Equity Issuance | USD | 1 | us-gaap/2025 | Equity Components= Parent; | |||
| 0001213900-25-044193 | 20250331 | Operating Lease Liability Current | 181000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20241231 | Prepaid Expense And Other Assets Current | 1291000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Proceeds From Shortterm Deposits | 19000000.0000 | USD | 1 | 0001213900-25-044193 | |||
| 0001213900-25-044193 | 20250331 | Profit Loss | USD | 1 | us-gaap/2025 | Equity Components= Noncontrolling Interest; | represent amounts less than $1 | ||
| 0001213900-25-044193 | 20250331 | Profit Loss | -7642000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-044193 | 20240331 | Repayments Of Debt | 19000000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Share Based Compensation | 1294000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Share Based Compensation | 197000.0000 | USD | 1 | us-gaap/2025 | Award Type= Performance Shares; | ||
| 0001213900-25-044193 | 20240331 | Stock Issued During Period Value Share Based Compensation | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | |||
| 0001213900-25-044193 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 41228782.0000 | shares | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Contract With Customer Liability Noncurrent | 2000000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20241231 | Employee Rights Upon Retirement Noncurrent | 30000.0000 | USD | 0 | 0001213900-25-044193 | |||
| 0001213900-25-044193 | 20241231 | Equity Securities F V N I Noncurrent | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-044193 | 20240331 | General And Administrative Expense | 1783000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -7058000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Interest Paid Net | 571000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20241231 | Investment Owned At Fair Value | 548000.0000 | USD | 0 | us-gaap/2025 | Investment Type= Warrant; Vesting= Share Based Compensation Award Tranche Two; | ||
| 0001213900-25-044193 | 20250331 | Investment Owned At Fair Value | 15823000.0000 | USD | 0 | us-gaap/2025 | Vesting= Share Based Compensation Award Tranche Two; | ||
| 0001213900-25-044193 | 20241231 | Liabilities Current | 5685000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20241231 | Liabilities Noncurrent | 4246000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Marketable Securities Current | 199000.0000 | USD | 0 | us-gaap/2025 | Information By Category Of Debt Security= Entera; | ||
| 0001213900-25-044193 | 20250331 | Net Cash Provided By Used In Financing Activities | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-044193 | 20250331 | Operating Lease Liability Noncurrent | 120000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250228 | Payments To Acquire Equity Method Investments | 7000000.0000 | USD | 0 | us-gaap/2025 | Schedule Of Equity Method Investment Equity Method Investee Name= Royalty Vest; | ||
| 0001213900-25-044193 | 20240331 | Payments To Acquire Property Plant And Equipment | 2000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Proceeds From Loan To An Equity Method Investment | 2736000.0000 | USD | 1 | 0001213900-25-044193 | |||
| 0001213900-25-044193 | 20250331 | Proceeds From Shortterm Deposits | 28450000.0000 | USD | 1 | 0001213900-25-044193 | |||
| 0001213900-25-044193 | 20240331 | Profit Loss | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-044193 | 20240331 | Profit Loss | -2000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Noncontrolling Interest; | ||
| 0001213900-25-044193 | 20250331 | Property Plant And Equipment Net | 671000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Shares Outstanding | 40851000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-044193 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -918000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Noncontrolling Interest; | ||
| 0001213900-25-044193 | 20250331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 491000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-044193 | 20240331 | Stock Issued During Period Value Share Based Compensation | 1282000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Stock Issued During Period Value Share Based Compensation | 2000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-044193 | 20250331 | Stock Issued During Period Value Share Based Compensation | 2178000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-044193 | 20250331 | Stock Issued During Period Value Share Based Compensation | 11000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-044193 | 20250331 | Change In Accrued Interest On Shortterm Borrowings | USD | 1 | 0001213900-25-044193 | ||||
| 0001213900-25-044193 | 20250331 | Deposits Assets Current | 26701000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Deposits Assets Noncurrent | 2000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -1000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Income Tax Expense Benefit | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-044193 | 20250331 | Increase Decrease In Other Noncurrent Liabilities | -60000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20241231 | Investment Owned At Fair Value | 18322000.0000 | USD | 0 | us-gaap/2025 | Vesting= Share Based Compensation Award Tranche Two; | ||
| 0001213900-25-044193 | 20241231 | Marketable Securities Current | 3441000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20241231 | Marketable Securities Current | 248000.0000 | USD | 0 | us-gaap/2025 | Information By Category Of Debt Security= Entera; | ||
| 0001213900-25-044193 | 20250331 | Marketable Securities Current | 3051000.0000 | USD | 0 | us-gaap/2025 | Information By Category Of Debt Security= Scilex; | ||
| 0001213900-25-044193 | 20250331 | Marketable Securities Noncurrent | 3524000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20241231 | Minority Interest | -918000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Net Cash Provided By Used In Investing Activities | 29998000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Net Cash Provided By Used In Investing Activities | 23616000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Net Income Loss Attributable To Noncontrolling Interest | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-044193 | 20240331 | Noncontrolling Interest Increase From Subsidiary Equity Issuance | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001213900-25-044193 | 20250331 | Operating Income Loss | -4500000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20241231 | Operating Lease Right Of Use Asset | 414000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Other Assets Noncurrent | 32000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Payments To Acquire Short Term Investments | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-044193 | 20250331 | Proceeds From Sale Of Other Investments | 877000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Profit Loss | 1536000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-044193 | 20250331 | Profit Loss | -7642000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20241231 | Shares Outstanding | 39920000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-044193 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 162893000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 163821000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Parent; | ||
| 0001213900-25-044193 | 20240331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -156020000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-044193 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -176616000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-044193 | 20250331 | Stock Issued During Period Shares Share Based Compensation | 931000.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-044193 | 20241231 | Additional Paid In Capital Common Stock | 322401000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Additional Paid In Capital Common Stock | 324579000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20241231 | Deposits Assets Noncurrent | 2000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Earnings Per Share Basic | 0.0400 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Earnings Per Share Basic | -0.1900 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20241231 | Equity Securities Fv Ni | 28788000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Equity Securities Fv Ni | 25732000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Equity Securities F V N I Noncurrent | 4265000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Gross Profit | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-044193 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | 1534000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Income Tax Expense Benefit | 584000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Interest Received | 1183000.0000 | USD | 1 | 0001213900-25-044193 | |||
| 0001213900-25-044193 | 20241231 | Investment Owned At Fair Value | 16486000.0000 | USD | 0 | us-gaap/2025 | Investment Type= Total; Vesting= Share Based Compensation Award Tranche One; | ||
| 0001213900-25-044193 | 20241231 | Investment Owned At Fair Value | 15798000.0000 | USD | 0 | us-gaap/2025 | Investment Type= Tranche B Note; Vesting= Share Based Compensation Award Tranche Two; | ||
| 0001213900-25-044193 | 20250331 | Investment Owned At Fair Value | 1906000.0000 | USD | 0 | us-gaap/2025 | Investment Type= Royalty Purchase Agreement; Vesting= Share Based Compensation Award Tranche Two; | ||
| 0001213900-25-044193 | 20250331 | Investment Owned At Fair Value | 13893000.0000 | USD | 0 | us-gaap/2025 | Investment Type= Total; Vesting= Share Based Compensation Award Tranche One; | ||
| 0001213900-25-044193 | 20241231 | Marketable Securities Noncurrent | 3524000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Minority Interest | -918000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Net Cash Provided By Used In Financing Activities | -19000000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Noncontrolling Interest Increase From Subsidiary Equity Issuance | 12000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Noncontrolling Interest; | ||
| 0001213900-25-044193 | 20240331 | Noncontrolling Interest Increase From Subsidiary Equity Issuance | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | |||
| 0001213900-25-044193 | 20241231 | Operating Lease Liability Noncurrent | 156000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20241231 | Other Assets Noncurrent | 32000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Payments To Acquire Loans Held For Investment | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-044193 | 20240331 | Proceeds From Sale Of Other Investments | 15000000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Repayments Of Debt | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-044193 | 20240331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 165721000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -918000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Noncontrolling Interest; | ||
| 0001213900-25-044193 | 20250331 | Stock Issued During Period Value Share Based Compensation | USD | 1 | us-gaap/2025 | Equity Components= Noncontrolling Interest; | |||
| 0001213900-25-044193 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 74516000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-044193 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0120 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Cost Of Revenue | 1987000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Depreciation | 30000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Earnings Per Share Diluted | 0.0400 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Earnings Per Share Diluted | -0.1900 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Fair Value Adjustment Of Warrants | -3748000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Increase Decrease In Employee Related Liabilities | 1000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Interest Expense Nonoperating | 592000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20241231 | Investment Owned At Fair Value | 7387000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Investment Owned At Fair Value | 1625000.0000 | USD | 0 | us-gaap/2025 | Investment Type= Subsequent Penny Warrants; Vesting= Share Based Compensation Award Tranche One; | ||
| 0001213900-25-044193 | 20250331 | Investment Owned At Fair Value | 184000.0000 | USD | 0 | us-gaap/2025 | Investment Type= Warrant; Vesting= Share Based Compensation Award Tranche Two; | ||
| 0001213900-25-044193 | 20241231 | Liabilities And Stockholders Equity | 155278000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Marketable Securities Current | 445000.0000 | USD | 0 | us-gaap/2025 | Information By Category Of Debt Security= D N A; | ||
| 0001213900-25-044193 | 20240331 | Net Income Loss | 1536000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20241231 | Operating Lease Liability Current | 216000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20241231 | Other Liabilities Noncurrent | 60000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Profit Loss | 1534000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Profit Loss | 1536000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Parent; | ||
| 0001213900-25-044193 | 20250331 | Profit Loss | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001213900-25-044193 | 20250331 | Profit Loss | -7642000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Parent; | ||
| 0001213900-25-044193 | 20240331 | Research And Development Expense | 1179000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Research And Development Expense | 2206000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Revenues | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-044193 | 20250331 | Revenues | 2000000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20231231 | Shares Outstanding | 40339000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-044193 | 20241231 | Stockholders Equity | 146265000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 485000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-044193 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 145347000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Stock Issued During Period Shares Share Based Compensation | 180000.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-044193 | 20250331 | Stock Issued During Period Value Share Based Compensation | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | |||
| 0001213900-25-044193 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 40835953.0000 | shares | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 41228782.0000 | shares | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20241231 | Assets | 155278000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20241231 | Accounts Payable And Accrued Liabilities Current | 5140000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Accounts Payable And Accrued Liabilities Current | 5275000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 9055000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 54420000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 9521000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Change In Accrued Interest On Shortterm Borrowings | -21000.0000 | USD | 1 | 0001213900-25-044193 | |||
| 0001213900-25-044193 | 20250331 | Common Stock Shares Authorized | 60000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20241231 | Common Stock Shares Issued | 39919545.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Common Stock Shares Issued | 40850455.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -1000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Equity Method Investments | 640000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Fair Value Adjustment Of Warrants | 3348000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Increase Decrease In Employee Related Liabilities | 3000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Interest Received | 1341000.0000 | USD | 1 | 0001213900-25-044193 | |||
| 0001213900-25-044193 | 20241231 | Investment Owned At Fair Value | 2772000.0000 | USD | 0 | us-gaap/2025 | Investment Type= Subsequent Penny Warrants; Vesting= Share Based Compensation Award Tranche One; | ||
| 0001213900-25-044193 | 20241231 | Investment Owned At Fair Value | 13714000.0000 | USD | 0 | us-gaap/2025 | Investment Type= Tranche A Note; Vesting= Share Based Compensation Award Tranche One; | ||
| 0001213900-25-044193 | 20250331 | Investment Owned At Fair Value | 12268000.0000 | USD | 0 | us-gaap/2025 | Investment Type= Tranche A Note; Vesting= Share Based Compensation Award Tranche One; | ||
| 0001213900-25-044193 | 20250331 | Marketable Securities Current | 3695000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Net Cash Provided By Used In Operating Activities | -1476000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Net Income Loss | -7642000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Net Income Loss Attributable To Noncontrolling Interest | -2000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Noncontrolling Interest Increase From Subsidiary Equity Issuance | 12000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Nonoperating Income Expense | 5088000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Operating Income Loss | -2962000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Operating Lease Right Of Use Asset | 342000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Other Liabilities Noncurrent | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-044193 | 20250331 | Payments To Acquire Property Plant And Equipment | 3000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Payments To Acquire Short Term Investments | 4000000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20241231 | Property Plant And Equipment Net | 698000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20241231 | Retained Earnings Accumulated Deficit | -176616000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 320892000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-044193 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -928000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Noncontrolling Interest; | ||
| 0001213900-25-044193 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -157556000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-044193 | 20240331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 487000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-044193 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 146265000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Parent; | ||
| 0001213900-25-044193 | 20250331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 140812000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Parent; | ||
| 0001213900-25-044193 | 20240331 | Stock Issued During Period Value Share Based Compensation | 1282000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Parent; | ||
| 0001213900-25-044193 | 20250331 | Stock Issued During Period Value Share Based Compensation | 2189000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Assets | 147539000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Assets Current | 131476000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20241231 | Assets Noncurrent | 12057000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0120 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20241231 | Common Stock Shares Issued | 71429.0000 | shares | 0 | us-gaap/2025 | Related Party Transactions By Related Party= Scilex Holding Company; | ||
| 0001213900-25-044193 | 20250331 | Common Stock Shares Outstanding | 40850455.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Common Stock Value | 491000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Gross Profit | 13000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Increase Decrease In Accounts Payable And Accrued Liabilities | -185000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Increase Decrease In Contract With Customer Liability | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-044193 | 20250331 | Increase Decrease In Operating Lease Liability | 1000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -667000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Interest Paid Net | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-044193 | 20240331 | Investment In Equity Method | USD | 1 | 0001213900-25-044193 | ||||
| 0001213900-25-044193 | 20250331 | Investment In Equity Method | 390000.0000 | USD | 1 | 0001213900-25-044193 | |||
| 0001213900-25-044193 | 20250331 | Net Cash Provided By Used In Operating Activities | -3519000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Noncontrolling Interest Increase From Subsidiary Equity Issuance | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-044193 | 20250331 | Notes Payable Current | 36000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Payments To Acquire Investments | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-044193 | 20250331 | Payments To Acquire Investments | 1194000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Payments To Acquire Loans Held For Investment | 7000000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Proceeds From Loan To An Equity Method Investment | USD | 1 | 0001213900-25-044193 | ||||
| 0001213900-25-044193 | 20250331 | Repayments Of Debt | 69200000.0000 | USD | 1 | us-gaap/2025 | Debt Instrument= Tranche A Note; | ||
| 0001213900-25-044193 | 20250331 | Share Based Compensation | 2189000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Shares Outstanding | 40519000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-044193 | 20240331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 322172000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-044193 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 480000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-044193 | 20250331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 139894000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -918000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Noncontrolling Interest; | ||
| 0001213900-25-044193 | 20250331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -184258000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-044193 | 20240331 | Stock Issued During Period Value Share Based Compensation | USD | 1 | us-gaap/2025 | Equity Components= Noncontrolling Interest; | |||
| 0001213900-25-044193 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 41564007.0000 | shares | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Profit Loss | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001213900-25-044193 | 20241231 | Advance Payments For Real Estate | USD | 0 | 0001213900-25-044193 | ||||
| 0001213900-25-044193 | 20250331 | Assets Noncurrent | 16063000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20241231 | Common Stock Shares Authorized | 60000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20241231 | Contract With Customer Liability Noncurrent | 4000000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Cost Of Revenue | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-044193 | 20240331 | Foreign Currency Transaction Gain Loss After Tax | 5000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Foreign Currency Transaction Gain Loss After Tax | -130000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Gain On Amounts Funded In Respect Of Employee Rights Upon Retirement | 2000.0000 | USD | 1 | 0001213900-25-044193 | |||
| 0001213900-25-044193 | 20240331 | Increase Decrease In Other Noncurrent Liabilities | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-044193 | 20250331 | Interest Expense Nonoperating | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-044193 | 20250331 | Investment Owned At Fair Value | 5366000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Investment Owned At Fair Value | 13733000.0000 | USD | 0 | us-gaap/2025 | Investment Type= Tranche B Note; Vesting= Share Based Compensation Award Tranche Two; | ||
| 0001213900-25-044193 | 20250331 | Liabilities And Stockholders Equity | 147539000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20241231 | Marketable Securities Current | 424000.0000 | USD | 0 | us-gaap/2025 | Information By Category Of Debt Security= D N A; | ||
| 0001213900-25-044193 | 20241231 | Marketable Securities Current | 2769000.0000 | USD | 0 | us-gaap/2025 | Information By Category Of Debt Security= Scilex; | ||
| 0001213900-25-044193 | 20250331 | Nonoperating Income Expense | -2558000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20241231 | Notes Payable Current | 329000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Payments To Acquire Equity Method Investments | 250000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Prepaid Expense And Other Assets Current | 832000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Profit Loss | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-044193 | 20250331 | Retained Earnings Accumulated Deficit | -184258000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20250331 | Stockholders Equity | 140812000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044193 | 20240331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 166639000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Parent; | ||
| 0001213900-25-044193 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 322401000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-044193 | 20250331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 324579000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-044193 | 20240331 | Stock Issued During Period Value Share Based Compensation | 1280000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-044193 | 20250331 | Stock Issued During Period Value Share Based Compensation | 2189000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Parent; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | 0 | 0 | monetary | D | D | Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | Amount of increase (decrease) from effect of exchange rate change on cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; held in foreign currency; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Operating Lease Liability Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Increase Decrease In Contract With Customer Liability | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Contract with Customer, Liability | Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash Provided by (Used in) Investing Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets. |
| Common Stock Shares Authorized | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Earnings Per Share Diluted | us-gaap/2025 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Property Plant And Equipment Net | us-gaap/2025 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation | Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| General And Administrative Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Commitments And Contingencies | us-gaap/2025 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Increase Decrease In Operating Lease Liability | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Operating Lease Liability | Amount of increase (decrease) in obligation for operating lease. |
| Noncontrolling Interest Increase From Subsidiary Equity Issuance | us-gaap/2025 | 0 | 0 | monetary | D | C | Noncontrolling Interest, Increase from Subsidiary Equity Issuance | Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders. |
| Payments To Acquire Equity Method Investments | us-gaap/2025 | 0 | 0 | monetary | D | C | Payments to Acquire Equity Method Investments | The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence. |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2025 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Change In Accrued Interest On Shortterm Borrowings | 0001213900-25-044193 | 1 | 0 | monetary | D | C | Change In Accrued Interest On Shortterm Borrowings | Change in accrued interest on short-term borrowings. |
| Employee Rights Upon Retirement Noncurrent | 0001213900-25-044193 | 1 | 0 | monetary | I | C | Employee Rights Upon Retirement Noncurrent | Represents the amount of employee rights upon retirement. |
| Deposits Assets Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Deposits Assets, Current | Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter. |
| Profit Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. |
| Common Stock Shares Issued | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Minority Interest | us-gaap/2025 | 0 | 0 | monetary | I | C | Equity, Attributable to Noncontrolling Interest | Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity. |
| Payments To Acquire Loans Held For Investment | us-gaap/2025 | 0 | 0 | monetary | D | C | Payment for Acquisition, Loan, Held-for-Investment | The cash outflow associated with purchasing loans held for investment purposes during the period. |
| Stock Issued During Period Value Share Based Compensation | us-gaap/2025 | 0 | 0 | monetary | D | C | Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture | Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). |
| Proceeds From Loan To An Equity Method Investment | 0001213900-25-044193 | 1 | 0 | monetary | D | D | Proceeds From Loan To An Equity Method Investment | The amount of proceeds from loan to equity method investment. |
| Equity Securities F V N I Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | D | Equity Securities, FV-NI, Noncurrent | Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as noncurrent. |
| Liabilities Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities, Noncurrent | Amount of obligation due after one year or beyond the normal operating cycle, if longer. |
| Payments To Acquire Short Term Investments | us-gaap/2025 | 0 | 0 | monetary | D | C | Payments to Acquire Short-Term Investments | The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term. |
| Repayments Of Debt | us-gaap/2025 | 0 | 0 | monetary | D | C | Repayments of Debt | Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation. |
| Operating Lease Liability Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
| Operating Income Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Research And Development Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Accounts Payable And Accrued Liabilities Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Accounts Payable and Accrued Liabilities, Current | Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2025 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | |
| Contract With Customer Liability Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | C | Contract with Customer, Liability, Noncurrent | Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent. |
| Cost Of Revenue | us-gaap/2025 | 0 | 0 | monetary | D | D | Cost of Revenue | The aggregate cost of goods produced and sold and services rendered during the reporting period. |
| Depreciation | us-gaap/2025 | 0 | 0 | monetary | D | D | Depreciation | The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. |
| Marketable Securities Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | D | Marketable Securities, Noncurrent | Amount of investment in marketable security, classified as noncurrent. |
| Operating Lease Right Of Use Asset | us-gaap/2025 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Net Income Loss Attributable To Noncontrolling Interest | us-gaap/2025 | 0 | 0 | monetary | D | D | Net Income (Loss) Attributable to Noncontrolling Interest | Amount of Net Income (Loss) attributable to noncontrolling interest. |
| Advance Payments For Real Estate | 0001213900-25-044193 | 1 | 0 | monetary | I | D | Advance Payments For Real Estate | The amount of advance payment made for real estate. |
| Other Liabilities Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | C | Other Liabilities, Noncurrent | Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer. |
| Investment In Equity Method | 0001213900-25-044193 | 1 | 0 | monetary | D | C | Investment In Equity Method | The amount of investment in equity method. |
| Earnings Per Share Basic | us-gaap/2025 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Payments To Acquire Property Plant And Equipment | us-gaap/2025 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
| Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Fair Value Adjustment Of Warrants | us-gaap/2025 | 0 | 0 | monetary | D | D | Fair Value Adjustment of Warrants | Amount of expense (income) related to adjustment to fair value of warrant liability. |
| Foreign Currency Transaction Gain Loss After Tax | us-gaap/2025 | 0 | 0 | monetary | D | C | Gain (Loss), Foreign Currency Transaction, after Tax | Amount, after tax, of realized and unrealized gain (loss) from foreign currency transaction. |
| Increase Decrease In Employee Related Liabilities | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Employee Related Liabilities | The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Assets | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Liabilities Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash Provided by (Used in) Financing Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit. |
| Common Stock Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Assets Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets, Noncurrent | Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. |
| Deposits Assets Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | D | Deposits Assets, Noncurrent | Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer. |
| Investment Owned At Fair Value | us-gaap/2025 | 0 | 0 | monetary | I | D | Investment Owned, Fair Value | Fair value of investment in security owned. |
| Marketable Securities Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Marketable Securities, Current | Amount of investment in marketable security, classified as current. |
| Nonoperating Income Expense | us-gaap/2025 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Notes Payable Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Notes Payable, Current | Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer. |
| Other Assets Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | D | Other Assets, Noncurrent | Amount of noncurrent assets classified as other. |
| Proceeds From Sale Of Other Investments | us-gaap/2025 | 0 | 0 | monetary | D | D | Proceeds from Sale of Other Investments | Amount of cash inflow from the sale of investments classified as other. |
| Liabilities And Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Net Income Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2025 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Interest Paid Net | us-gaap/2025 | 0 | 0 | monetary | D | C | Interest Paid, Excluding Capitalized Interest, Operating Activity | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. |
| Equity Method Investments | us-gaap/2025 | 0 | 0 | monetary | I | D | Equity Method Investments | This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. |
| Equity Securities Fv Ni | us-gaap/2025 | 0 | 0 | monetary | I | D | Equity Securities, FV-NI, Current | Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current. |
| Interest Expense Nonoperating | us-gaap/2025 | 0 | 0 | monetary | D | D | Interest Expense, Nonoperating | Amount of interest expense classified as nonoperating. |
| Prepaid Expense And Other Assets Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Stock Issued During Period Shares Share Based Compensation | us-gaap/2025 | 0 | 0 | shares | D | Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture | Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP). | |
| Assets Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Gross Profit | us-gaap/2025 | 0 | 0 | monetary | D | C | Gross Profit | Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. |
| Income Tax Expense Benefit | us-gaap/2025 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Revenues | us-gaap/2025 | 0 | 0 | monetary | D | C | Revenues | Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). |
| Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | us-gaap/2025 | 0 | 0 | monetary | I | C | Equity, Including Portion Attributable to Noncontrolling Interest | Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity. |
| Payments To Acquire Investments | us-gaap/2025 | 0 | 0 | monetary | D | C | Payments to Acquire Investments | The cash outflow associated with the purchase of all investments (debt, security, other) during the period. |
| Share Based Compensation | us-gaap/2025 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Gain On Amounts Funded In Respect Of Employee Rights Upon Retirement | 0001213900-25-044193 | 1 | 0 | monetary | D | C | Gain On Amounts Funded In Respect Of Employee Rights Upon Retirement | Gain on amounts funded in respect of employee rights upon retirement. |
| Proceeds From Shortterm Deposits | 0001213900-25-044193 | 1 | 0 | monetary | D | D | Proceeds From Shortterm Deposits | Amount of proceeds from short-term deposits. |
| Additional Paid In Capital Common Stock | us-gaap/2025 | 0 | 0 | monetary | I | C | Additional Paid in Capital, Common Stock | Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | 0 | 0 | monetary | I | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Increase Decrease In Other Noncurrent Liabilities | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Other Noncurrent Liabilities | Amount of increase (decrease) in noncurrent operating liabilities classified as other. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2025 | 0 | 0 | monetary | D | Cash Provided by (Used in) Operating Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity. | |
| Retained Earnings Accumulated Deficit | us-gaap/2025 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Common Stock Value | us-gaap/2025 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Interest Received | 0001213900-25-044193 | 1 | 0 | monetary | D | C | Interest Received | Represents amount of interest received. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001213900-25-044193 | 2 | 37 | BS | 0 | H | Minority Interest | us-gaap/2025 | Non-controlling interests | 0 |
| 0001213900-25-044193 | 2 | 2 | BS | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | Cash and cash equivalents | 0 |
| 0001213900-25-044193 | 6 | 29 | CF | 0 | H | Repayments Of Debt | us-gaap/2025 | Loans repaid | 1 |
| 0001213900-25-044193 | 6 | 30 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2025 | Total net cash used in financing activities | 0 |
| 0001213900-25-044193 | 6 | 31 | CF | 0 | H | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS | 0 |
| 0001213900-25-044193 | 6 | 32 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2025 | INCREASE IN CASH AND CASH EQUIVALENTS | 0 |
| 0001213900-25-044193 | 6 | 33 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD | 0 |
| 0001213900-25-044193 | 6 | 34 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | CASH AND CASH EQUIVALENTS AT END OF PERIOD | 0 |
| 0001213900-25-044193 | 6 | 36 | CF | 0 | H | Interest Received | 0001213900-25-044193 | Interest received | 0 |
| 0001213900-25-044193 | 6 | 37 | CF | 0 | H | Interest Paid Net | us-gaap/2025 | Interest paid | 1 |
| 0001213900-25-044193 | 6 | 39 | CF | 0 | H | Investment In Equity Method | 0001213900-25-044193 | Investment in equity method | 0 |
| 0001213900-25-044193 | 2 | 3 | BS | 0 | H | Deposits Assets Current | us-gaap/2025 | Short-term deposits | 0 |
| 0001213900-25-044193 | 2 | 4 | BS | 0 | H | Marketable Securities Current | us-gaap/2025 | Marketable securities | 0 |
| 0001213900-25-044193 | 2 | 5 | BS | 0 | H | Equity Securities Fv Ni | us-gaap/2025 | Investments at fair value | 0 |
| 0001213900-25-044193 | 2 | 6 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2025 | Prepaid expenses and other current assets | 0 |
| 0001213900-25-044193 | 2 | 7 | BS | 0 | H | Assets Current | us-gaap/2025 | Total current assets | 0 |
| 0001213900-25-044193 | 2 | 9 | BS | 0 | H | Deposits Assets Noncurrent | us-gaap/2025 | Long-term deposits | 0 |
| 0001213900-25-044193 | 2 | 10 | BS | 0 | H | Investment Owned At Fair Value | us-gaap/2025 | Investments at fair value | 0 |
| 0001213900-25-044193 | 2 | 11 | BS | 0 | H | Advance Payments For Real Estate | 0001213900-25-044193 | Advance payments for real estate | 0 |
| 0001213900-25-044193 | 2 | 12 | BS | 0 | H | Equity Method Investments | us-gaap/2025 | Equity method investee | 0 |
| 0001213900-25-044193 | 2 | 13 | BS | 0 | H | Equity Securities F V N I Noncurrent | us-gaap/2025 | Loan to an equity method investee | 0 |
| 0001213900-25-044193 | 2 | 14 | BS | 0 | H | Marketable Securities Noncurrent | us-gaap/2025 | Other non-marketable equity securities | 0 |
| 0001213900-25-044193 | 2 | 15 | BS | 0 | H | Other Assets Noncurrent | us-gaap/2025 | Amounts funded in respect of employee rights upon retirement | 0 |
| 0001213900-25-044193 | 2 | 16 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2025 | Property and equipment, net | 0 |
| 0001213900-25-044193 | 2 | 17 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2025 | Operating lease right-of-use assets | 0 |
| 0001213900-25-044193 | 2 | 18 | BS | 0 | H | Assets Noncurrent | us-gaap/2025 | Total long-term assets | 0 |
| 0001213900-25-044193 | 2 | 19 | BS | 0 | H | Assets | us-gaap/2025 | Total assets | 0 |
| 0001213900-25-044193 | 2 | 21 | BS | 0 | H | Accounts Payable And Accrued Liabilities Current | us-gaap/2025 | Accounts payable and accrued expenses | 0 |
| 0001213900-25-044193 | 2 | 22 | BS | 0 | H | Notes Payable Current | us-gaap/2025 | Payable to related parties | 0 |
| 0001213900-25-044193 | 2 | 23 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2025 | Operating lease liabilities | 0 |
| 0001213900-25-044193 | 2 | 24 | BS | 0 | H | Liabilities Current | us-gaap/2025 | Total current liabilities | 0 |
| 0001213900-25-044193 | 2 | 26 | BS | 0 | H | Contract With Customer Liability Noncurrent | us-gaap/2025 | Long-term deferred revenues | 0 |
| 0001213900-25-044193 | 2 | 27 | BS | 0 | H | Employee Rights Upon Retirement Noncurrent | 0001213900-25-044193 | Employee rights upon retirement | 0 |
| 0001213900-25-044193 | 2 | 28 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2025 | Operating lease liabilities | 0 |
| 0001213900-25-044193 | 2 | 29 | BS | 0 | H | Other Liabilities Noncurrent | us-gaap/2025 | Other liabilities | 0 |
| 0001213900-25-044193 | 2 | 30 | BS | 0 | H | Liabilities Noncurrent | us-gaap/2025 | Total long-term liabilities | 0 |
| 0001213900-25-044193 | 2 | 31 | BS | 0 | H | Commitments And Contingencies | us-gaap/2025 | COMMITMENTS (note 8) | 0 |
| 0001213900-25-044193 | 2 | 33 | BS | 0 | H | Common Stock Value | us-gaap/2025 | Common stock, $0.012 par value (60,000,000 authorized shares; 40,850,455 and 39,919,545 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively) | 0 |
| 0001213900-25-044193 | 2 | 34 | BS | 0 | H | Additional Paid In Capital Common Stock | us-gaap/2025 | Additional paid-in capital | 0 |
| 0001213900-25-044193 | 2 | 35 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2025 | Accumulated deficit | 0 |
| 0001213900-25-044193 | 2 | 36 | BS | 0 | H | Stockholders Equity | us-gaap/2025 | Total stockholders equity | 0 |
| 0001213900-25-044193 | 2 | 38 | BS | 0 | H | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | us-gaap/2025 | Total equity | 0 |
| 0001213900-25-044193 | 2 | 39 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2025 | Total liabilities and equity | 0 |
| 0001213900-25-044193 | 3 | 1 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2025 | Common stock, par value (in Dollars per share) | 0 |
| 0001213900-25-044193 | 3 | 2 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2025 | Common stock, shares authorized | 0 |
| 0001213900-25-044193 | 3 | 3 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2025 | Common stock, shares issued | 0 |
| 0001213900-25-044193 | 3 | 4 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2025 | Common stock, shares outstanding | 0 |
| 0001213900-25-044193 | 4 | 1 | IS | 0 | H | Revenues | us-gaap/2025 | REVENUES | 0 |
| 0001213900-25-044193 | 4 | 2 | IS | 0 | H | Cost Of Revenue | us-gaap/2025 | COST OF REVENUE | 1 |
| 0001213900-25-044193 | 4 | 3 | IS | 0 | H | Gross Profit | us-gaap/2025 | GROSS PROFIT | 0 |
| 0001213900-25-044193 | 4 | 4 | IS | 0 | H | Research And Development Expense | us-gaap/2025 | RESEARCH AND DEVELOPMENT EXPENSES | 1 |
| 0001213900-25-044193 | 4 | 5 | IS | 0 | H | General And Administrative Expense | us-gaap/2025 | GENERAL AND ADMINISTRATIVE EXPENSES | 1 |
| 0001213900-25-044193 | 4 | 6 | IS | 0 | H | Operating Income Loss | us-gaap/2025 | OPERATING LOSS | 0 |
| 0001213900-25-044193 | 4 | 7 | IS | 0 | H | Interest Expense Nonoperating | us-gaap/2025 | INTEREST EXPENSES | 1 |
| 0001213900-25-044193 | 4 | 8 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2025 | FINANCIAL INCOME (EXPENSES), NET | 0 |
| 0001213900-25-044193 | 4 | 9 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2025 | INCOME (LOSS) BEFORE TAX EXPENSES | 0 |
| 0001213900-25-044193 | 4 | 10 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2025 | TAX EXPENSES | 1 |
| 0001213900-25-044193 | 4 | 11 | IS | 0 | H | Profit Loss | us-gaap/2025 | NET INCOME (LOSS) | 0 |
| 0001213900-25-044193 | 4 | 13 | IS | 0 | H | Net Income Loss Attributable To Noncontrolling Interest | us-gaap/2025 | NON-CONTROLLING INTERESTS | 0 |
| 0001213900-25-044193 | 4 | 14 | IS | 0 | H | Net Income Loss | us-gaap/2025 | COMPANYS STOCKHOLDERS | 0 |
| 0001213900-25-044193 | 4 | 15 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2025 | BASIC INCOME (LOSS) PER SHARE OF COMMON STOCK (in Dollars per share) | 0 |
| 0001213900-25-044193 | 4 | 16 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2025 | DILUTED INCOME (LOSS) PER SHARE OF COMMON STOCK (in Dollars per share) | 0 |
| 0001213900-25-044193 | 4 | 17 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2025 | WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING BASIC INCOME (LOSS) PER SHARE OF COMMON STOCK (in Shares) | 0 |
| 0001213900-25-044193 | 4 | 18 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2025 | WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING DILUTED INCOME (LOSS) PER SHARE OF COMMON STOCK (in Shares) | 0 |
| 0001213900-25-044193 | 5 | 10 | EQ | 0 | H | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | us-gaap/2025 | BALANCE | 0 |
| 0001213900-25-044193 | 5 | 11 | EQ | 0 | H | Shares Outstanding | us-gaap/2025 | BALANCE (in Shares) | 0 |
| 0001213900-25-044193 | 5 | 12 | EQ | 0 | H | Stock Issued During Period Value Share Based Compensation | us-gaap/2025 | STOCK-BASED COMPENSATION | 0 |
| 0001213900-25-044193 | 5 | 13 | EQ | 0 | H | Stock Issued During Period Shares Share Based Compensation | us-gaap/2025 | STOCK-BASED COMPENSATION (in Shares) | 0 |
| 0001213900-25-044193 | 5 | 14 | EQ | 0 | H | Noncontrolling Interest Increase From Subsidiary Equity Issuance | us-gaap/2025 | STOCK-BASED COMPENSATION OF SUBSIDIARY | 0 |
| 0001213900-25-044193 | 5 | 15 | EQ | 0 | H | Profit Loss | us-gaap/2025 | NET INCOME (LOSS) | 0 |
| 0001213900-25-044193 | 5 | 16 | EQ | 0 | H | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | us-gaap/2025 | BALANCE | 0 |
| 0001213900-25-044193 | 5 | 17 | EQ | 0 | H | Shares Outstanding | us-gaap/2025 | BALANCE (in Shares) | 0 |
| 0001213900-25-044193 | 6 | 2 | CF | 0 | H | Profit Loss | us-gaap/2025 | Net income (loss) | 0 |
| 0001213900-25-044193 | 6 | 4 | CF | 0 | H | Depreciation | us-gaap/2025 | Depreciation | 0 |
| 0001213900-25-044193 | 6 | 5 | CF | 0 | H | Foreign Currency Transaction Gain Loss After Tax | us-gaap/2025 | Exchange differences and interest on deposits | 1 |
| 0001213900-25-044193 | 6 | 6 | CF | 0 | H | Fair Value Adjustment Of Warrants | us-gaap/2025 | Changes in fair value of investments | 0 |
| 0001213900-25-044193 | 6 | 7 | CF | 0 | H | Share Based Compensation | us-gaap/2025 | Stock-based compensation | 0 |
| 0001213900-25-044193 | 6 | 8 | CF | 0 | H | Gain On Amounts Funded In Respect Of Employee Rights Upon Retirement | 0001213900-25-044193 | Funded in respect of employee rights upon retirement | 1 |
| 0001213900-25-044193 | 6 | 9 | CF | 0 | H | Change In Accrued Interest On Shortterm Borrowings | 0001213900-25-044193 | Change in accrued interest on short-term borrowings to maturity | 1 |
| 0001213900-25-044193 | 6 | 11 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2025 | Prepaid expenses and other current assets | 1 |
| 0001213900-25-044193 | 6 | 12 | CF | 0 | H | Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2025 | Accounts payable, accrued expenses and related parties | 0 |
| 0001213900-25-044193 | 6 | 13 | CF | 0 | H | Increase Decrease In Operating Lease Liability | us-gaap/2025 | Net changes in operating lease | 0 |
| 0001213900-25-044193 | 6 | 14 | CF | 0 | H | Increase Decrease In Contract With Customer Liability | us-gaap/2025 | Deferred revenue | 0 |
| 0001213900-25-044193 | 6 | 15 | CF | 0 | H | Increase Decrease In Employee Related Liabilities | us-gaap/2025 | Liability for employee rights upon retirement | 0 |
| 0001213900-25-044193 | 6 | 16 | CF | 0 | H | Increase Decrease In Other Noncurrent Liabilities | us-gaap/2025 | Other liabilities | 0 |
| 0001213900-25-044193 | 6 | 17 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2025 | Total net cash used in operating activities | 0 |
| 0001213900-25-044193 | 6 | 19 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2025 | Purchase of property and equipment | 1 |
| 0001213900-25-044193 | 6 | 20 | CF | 0 | H | Payments To Acquire Short Term Investments | us-gaap/2025 | Purchase of short-term deposits | 1 |
| 0001213900-25-044193 | 6 | 21 | CF | 0 | H | Proceeds From Shortterm Deposits | 0001213900-25-044193 | Proceeds from redemption of short-term deposits | 0 |
| 0001213900-25-044193 | 6 | 22 | CF | 0 | H | Payments To Acquire Loans Held For Investment | us-gaap/2025 | Loan to investment in equity method | 1 |
| 0001213900-25-044193 | 6 | 23 | CF | 0 | H | Payments To Acquire Equity Method Investments | us-gaap/2025 | Equity method investee | 1 |
| 0001213900-25-044193 | 6 | 24 | CF | 0 | H | Proceeds From Loan To An Equity Method Investment | 0001213900-25-044193 | Proceeds from loan to an equity method investee | 0 |
| 0001213900-25-044193 | 6 | 25 | CF | 0 | H | Payments To Acquire Investments | us-gaap/2025 | Advance payments for real estate | 1 |
| 0001213900-25-044193 | 6 | 26 | CF | 0 | H | Proceeds From Sale Of Other Investments | us-gaap/2025 | Proceeds from investments | 0 |
| 0001213900-25-044193 | 6 | 27 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2025 | Total net cash provided by investing activities | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |